Medical Equipment

Diabetes Care Devices Market Outlook 2026–2030 Driven By Growth Factors And Projections

April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Diabetes Care Devices Market Between 2026 And 2030?

The diabetes care devices market size has experienced rapid growth in recent years. It is anticipated to expand from $73.91 billion in 2025 to $82.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.3%. The historical expansion of this market can be attributed to factors such as the rising global diabetes prevalence, improved access to glucose monitoring devices, the expansion of outpatient diabetes care, increased awareness of self-monitoring practices, and the growing availability of disposable testing supplies.

The diabetes care devices market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $130.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. This projected growth stems from several factors, including the escalating need for real-time glucose monitoring, the rising uptake of closed-loop insulin systems, the broadening of digital diabetes management platforms, a heightened emphasis on personalized diabetes care, and increased healthcare spending in chronic disease management. Key developments expected during this period involve a greater embrace of continuous glucose monitoring devices, increased utilization of smart insulin delivery systems, deeper integration of mobile health platforms, the growth of interconnected diabetes management ecosystems, and a stronger focus on patient-centered monitoring solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

What Significant Factors Are Influencing The Diabetes Care Devices Market Expansion?

Rising healthcare spending is anticipated to drive the expansion of the diabetes care device market in the coming years. Healthcare expenditures encompass the total funds allocated for healthcare-related services, products, and activities over a specified duration, typically evaluated at an individual, community, national, or global level. This increase in healthcare expenditures, alongside improved access to healthcare services and a growing number of diabetes diagnoses, encourages greater investment in research and development, which facilitates the advancement of diabetes care devices such as enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) rose by 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures increased by 10.4% to $1,519.7 billion in 2023, outpacing the 3.2% growth seen in 2022. Therefore, increasing healthcare expenditure will propel the growth of the diabetes care device market going forward.

How Is The Diabetes Care Devices Market Categorized Across Its Segment Groups?

The diabetes care devices market covered in this report is segmented –

1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

2) By Type of Expenditure: Public, Private

3) By Consumable Type: Instruments Or Equipment, Disposables

4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

What Trends Are Affecting The Direction Of The Diabetes Care Devices Market?

Leading firms within the diabetes care devices market are concentrating on creating sophisticated solutions, including real-time glucose monitoring technology, to improve precision, ease of use, and proactive disease management. This real-time glucose monitoring capability offers automated, continuous glucose readings and notifications, empowering individuals with diabetes to make prompt choices and mitigate health hazards. A prime example is the FreeStyle Libre 2 Plus, introduced in August 2025 by Abbott Laboratories, a US-based healthcare entity. This device provides ongoing minute-by-minute glucose measurements sent straight to a compatible smartphone, complemented by optional alerts for fluctuations in glucose levels. It aids in confident self-management of diabetes by delivering automated alerts, insights into past trends, and directional indicators, thereby eliminating the need for regular fingersticks. Operating via near-field communication and Bluetooth, the device is designed for wear for up to 15 days. Furthermore, it allows caregivers to access glucose updates via integrated digital health platforms. This technology contributes to improved patient safety by facilitating rapid interventions and boosts engagement through continuous insights that inform daily health decisions.

Which Firms Are Influencing Competition In The Diabetes Care Devices Market?

Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited

Get The Full Diabetes Care Devices Market Report:

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

Which Region Accounts For The Largest Portion Of The Diabetes Care Devices Market?

North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diabetes Care Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2026, By The Business Research Company

Pet Diabetes Care Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-devices-global-market-report

Insulin Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Digital Diabetes Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795